Paid Clinical Trials in Burlington, VT
As of August 2026, 160 paid clinical trials are recruiting in Burlington, Vermont. Compensation typically covers time, travel, and study visits, with stipends ranging from modest amounts for short outpatient studies to several thousand dollars for long or inpatient protocols.
Burlington offers studies at sites including University of Vermont Medical Center for conditions such as Heart Failure, Acute Myeloid Leukemia, Anatomic Stage II Breast Cancer AJCC v8, Breast Cancer. Both patients with specific conditions and healthy volunteers can qualify. Most trials offer free study-related medical care alongside compensation.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Trials by specialty in Burlington
Trials by drug in Burlington
Filter results
Newly added in Burlington
Posted to ClinicalTrials.gov within the last 60 days — these studies are just starting to recruit.
Observational Study of Decentralized Urine Optical Interaction Patterns Associated With Environmental Microplastic and Nanoplastic Exposure
A Study to Investigate CV Outcomes With Elecoglipron Compared With Placebo in Adult Participants With HFpEF or HFmrEF
143 clinical trials
A Study to Learn About a Clostridioides Difficile Vaccine in People 65 Years of Age and Older
A US Study That Observes How Parkinson's Disease Changes Over Time in Patients Who Still Have Movement Symptoms Despite Taking Parkinson's Medications
A Study of Imlunestrant (LY3484356) in Premenopausal Women With Estrogen Receptor-Positive (ER+) Human Epidermal Growth Factor Receptor 2 Negative (HER2-) Early Breast Cancer
A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence
A Study Investigating Subcutaneously Administered Pozelimab in Combination With Cemdisiran or Cemdisiran Alone in Adult Participants With Geographic Atrophy
Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS G12C-mutant Non-Small Cell Lung Cancer
A Study to Evaluate the Efficacy and Safety of Intravenous (IV) Prasinezumab in Participants With Early-Stage Parkinson's Disease
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
FORAGER-1: A Study of Vepugratinib (LY3866288; LOXO-435) in Participants With Cancer With a Change in a Gene Called FGFR3
Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AML
Transcatheter Mitral Valve Replacement With the Medtronic Intrepid™ TMVR System in Patients With Severe Symptomatic Mitral Regurgitation.
A Study to Test the Efficacy and Safety of Riliprubart Against the Usual Treatment of Intravenous Immunoglobulin (IVIg) in People With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
Safety and Tolerability of Ziftomenib Combinations in Patients With Relapsed/Refractory Acute Myeloid Leukemia
VO and Nivolumab vs Physician's Choice in Advanced Melanoma That Progressed on Anti-PD-1 & Anti-CTLA-4 Drugs [IGNYTE-3]
A Study to Investigate the Efficacy and Safety of Bemdaneprocel in Adults Who Have Parkinson's Disease
ELEVATE-HFpEF Clinical Study
PROACTIVE-HF-2 Trial Heart Failure NYHA Class II and III
Phase 2/3 Study of Participants With Recurrent Pericarditis Evaluating the Efficacy and Safety of KPL-387
REdo tranScatheter Aortic Valve Replacement for Transcatheter aOrtic Valve failuRE
Registry of Participants With Generalized Myasthenia Gravis Treated With Alexion C5 Inhibition Therapies (C5ITs)
A Study to Learn About the Safety, Tolerability, and Immunogenicity of a Fifth Dose of 6-Valent OspA-Based Lyme Disease Vaccine
A Study to Investigate the Efficacy, Safety and Tolerability of Votoplam in Participants With Huntington's Disease
Efficacy and Safety of a New Formulation of Oral Cladribine Compared With Placebo in Participants With Generalized Myasthenia Gravis (MyClad)
A Study of Mirikizumab (LY3074828) in Pediatric Participants With Crohn's Disease
CardiolRx in Recurrent Pericarditis (MAVERIC Phase-3)
A Study of JNJ-90301900 in Combination With Chemoradiation Followed by Consolidation Immunotherapy for Non-Small Cell Lung Cancer (NSCLC)
An Open-Label Pilot Study of VTX2735 in Recurrent Pericarditis
A Study to Compare TAK-881 and HYQVIA in Adults With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)
Endocardial Mapping With the CoreMap EP Mapping System
PumaRx Registry Trial
DFP-10917 in Combination With Venetoclax in Relapsed or Refractory Acute Myeloid Leukemia
MAPT Protocol: Fixation Versus Arthroplasty Surgical Treatments for Early Recovery After HIP Fracture (FASTER-HIP)
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
Testing Addition of an Anti-cancer Drug, Vorasidenib to Temozolomide, After Radiation for Advanced Brain Cancer
Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease
Pembrolizumab vs. Observation in People With Triple-negative Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Pembrolizumab
Vismodegib, FAK Inhibitor GSK2256098, Capivasertib, and Abemaciclib in Treating Patients With Progressive Meningiomas
mFOLFIRINOX Versus mFOLFOX With or Without Nivolumab for the Treatment of Advanced, Unresectable, or Metastatic HER2 Negative Esophageal, Gastroesophageal Junction, and Gastric Adenocarcinoma
Testing the Use of Combination Therapy in Adult Patients With Newly Diagnosed Multiple Myeloma, the EQUATE Trial
Top Research Study Locations in Burlington
Researchers run research studies in Burlington, VT at 25 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| University of Vermont Medical Center | Acute Myeloid Leukemia, Anatomic Stage II Breast Cancer AJCC v8, Acute Myeloid Leukemia Arising From Previous Myelodysplastic/Myeloproliferative Neoplasm | 78 |
| University of Vermont and State Agricultural College | Acute Myeloid Leukemia, Anatomic Stage II Breast Cancer AJCC v8, Acute Myeloid Leukemia Arising From Previous Myelodysplastic/Myeloproliferative Neoplasm | 46 |
| University of Vermont | Heart Failure, AML, AML With Mutated NPM1 | 26 |
| The University of Vermont Medical Center | Atrial Fibrillation, Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP), Generalized Myasthenia Gravis | 6 |
| The University of Vermont Medical Center Inc. | Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Neoplasm Metastasis | 6 |
| University of Vermont Cancer Center | Cancer, Diabetes, Leukemia, Myeloid, Acute | 3 |
| Burlington, VT Investigative | Acute Heart Failure, Heart Failure | 1 |
| Clinical Trial Site | Generalized Myasthenia Gravis | 1 |
| Decentralized / At-Home Participation (U.S.) | Healthy Adult Participants | 1 |
| Department of Orthopaedics & Rehabilitation The Larner College of Medicine at The University of Vermont | Shoulder Arthritis, Shoulder Disease, Shoulder Fractures | 1 |
| FIN-10053, Burlington, VT | Heart Failure | 1 |
| Fletcher Allen Health Care, University of Vermont Medical School | Glomerular Filtration Rate | 1 |
| Golisano Children's Hospital at University of Vermont Health | Acute Kidney Injury, Chronic Kidney Disease(CKD), Epidemiology | 1 |
| Investigational | Pericarditis, Pericarditis Acute, Recurrent Pericarditis | 1 |
| Local | Recurrent Pericarditis | 1 |
| Ohio State University-Telemedicine | Advanced Pancreatic Carcinoma, Metastatic Pancreatic Carcinoma, Stage II Pancreatic Cancer AJCC v8 | 1 |
| The University of Vermont Children's Hospital | Failed or Difficult Intubation, Sequela, Intubation Complication, Intubation; Difficult | 1 |
| The University of Vermont Larner College of Medicine | Traumatic Injury | 1 |
| The University of Vermont MC | Huntington Disease | 1 |
| The University of Vermont Medical Center, Inc | COPD | 1 |
| UVM Larner College of Medicine MMG/VCT | Clostridoides Difficile Associated Disease | 1 |
| UVM MC | Focal Epilepsy | 1 |
| University of Vemont | Opioid Use Disorder, Posttraumatic Stress Disorder | 1 |
| University of Vermont Medical Centre | Essential Tremor | 1 |
| University of Vermount and Sate Agricultural College | Cutaneous Melanoma, Stage II | 1 |
Active & Upcoming Studies in Burlington (2026)
Recruiting trials in Burlington grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Cancer & tumors (68 active studies)
- MM-CARE: Cardiovascular Risk Assessment in Adults With Multiple Myeloma · University of Vermont Medical Center
- Gut Microbiome Changes During Abemaciclib Therapy in Breast Cancer · University of Vermont Medical Center
Cardiovascular (18 active studies)
- MM-CARE: Cardiovascular Risk Assessment in Adults With Multiple Myeloma · University of Vermont Medical Center
- A Study to Investigate CV Outcomes With Elecoglipron Compared With Placebo in Adult Participants With HFpEF or HFmrEF · Phase 3 · AstraZeneca
Neurology & pain (5 active studies)
- SPENDD: Quantitative Sensory Testing and Analgesic Response for Painful Peripheral Neuropathy. · Phase 2 · University of Rochester
- Long-term Safety and Tolerability of BHV-7000 · Phase 2 · Biohaven Therapeutics Ltd.
Pediatric (3 active studies)
- Target Trial Emulation for Pharmacologic Treatment of Neonatal Opioid Withdrawal Syndrome · HELP for NOWS Consortium
- Emergency Care Action Plans for Infants with Medical Complexity · University of Vermont
Mental health & behavior (2 active studies)
- Nicotine Regulation for Dual Users of E-cigarettes and Cigarettes · Phase 2 · University of Vermont
- Remote Smoking Cessation in Hospitalized Cardiac Patients · University of Vermont Medical Center
Vaccines (1 active study)
Diabetes & metabolic (1 active study)
- Expanding the Support of Family Caregivers of Diverse Patients With Cancer and Diabetes · UNC Lineberger Comprehensive Cancer Center
Eye & vision (1 active study)
Common conditions studied in Burlington
- Heart Failure (7 active studies)
- Acute Myeloid Leukemia (6 active studies)
- Anatomic Stage II Breast Cancer AJCC v8 (3 active studies)
- Breast Cancer (3 active studies)
- Cancer (3 active studies)
- Carcinoma, Non-Small-Cell Lung (3 active studies)
Leading research sponsors in Burlington
- University of Vermont
- National Cancer Institute (NCI)
- University of Vermont Medical Center
- Children's Oncology Group
- NRG Oncology
Frequently asked questions
How many paid clinical trials are currently recruiting in Burlington?
There are approximately 160 recruiting clinical trials in Burlington, Vermont listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Burlington pay participants?
Most recruiting trials in Burlington compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Burlington?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Burlington?
The most common conditions under active study in Burlington include Heart Failure (7), Acute Myeloid Leukemia (6), Anatomic Stage II Breast Cancer AJCC v8 (3), Breast Cancer (3), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Burlington?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Burlington on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Burlington?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Burlington?
Recruiting research sites in Burlington include University of Vermont Medical Center, University of Vermont and State Agricultural College, University of Vermont, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Burlington right now?
The largest active categories in Burlington are Cancer & tumors (68), Cardiovascular (18), Neurology & pain (5). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.